Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision label v3.6.6 has been added to the study's record history. The previous revision label v3.6.5 is removed from the changes shown in the history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry (v3.6.5) was added to the study history, signaling an updated version of the record for the trial (NCT04919811).SummaryDifference0.1%

- Check50 days agoChange DetectedThe history now shows a new entry for Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a platform update to the record history and does not alter the study data or participant-facing details.SummaryDifference0.1%

- Check72 days agoChange DetectedAn updated revision entry v3.6.3 has been added to the study history, and the previous revision v3.6.2 has been removed.SummaryDifference0.1%

- Check79 days agoChange DetectedThe study record history now lists Revision: v3.6.2, replacing the older v3.6.0 entry and updating the page’s version history.SummaryDifference0.1%

- Check93 days agoChange DetectedThe history now shows that enrollment is closed for this study, and the latest version tag 'Revision: v3.6.0' has been added while the previous revision 'v3.5.5' was removed.SummaryDifference0.4%

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.